Today, I breakdown Sickle Cell Disease and Global Blood Therapeutics' Voxelotor. I write a more detailed article here: http://breakingbiotech.com/2018/11/13/026-global-blood-therapeutics-meager-approval-attempt/ Follow me on twitter @matthewlepoire Relevant Press Releases: http://ir.gbt.com/phoenix.zhtml?c=254105&p=irol-newsArticle&ID=2215253 http://ir.gbt.com/phoenix.zhtml?c=254105&p=irol-newsArticle&ID=2227616 http://ir.globalbloodtx.com/phoenix.zhtml?c=254105&p=irol-newsArticle&ID=2356168 Relevant Links: https://www.ncbi.nlm.nih.gov/pubmed/26758919 https://www.statnews.com/2018/09/13/global-blood-therapeutics-sickle-cell-fda/ gbt #sicklecelldisease